Yup - 35 states with 4 million patients ....as opposed to 25,000 in Australia....that's revenue...and that from the CEO Richard Hopkins.
If you disagree with that, you should sell you holding.....its not hard.
'you must be able to turn your trials into revenues, that is the only way you get a re-rate. Thats the 600 pound gorilla in the room'
I agree.
Clinical validation is the key to this, no matter what your overall view.
makes perfect sense to me...
GLTAH
Ann: Zelda to merge with US-based Ilera Therapeutics, page-136
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
